MedPath

Clinical Assessment - HominisTM Surgical System

Not Applicable
Conditions
Hysterectomy
Interventions
Device: HominisTM Surgical System
Registration Number
NCT04109989
Lead Sponsor
Memic Innovative Surgery
Brief Summary

A clinical research study designed to assess the HominisTM Surgical System in gynecological procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria
  1. Female above 18 years of age inclusive.
  2. Able to provide written informed consent.
  3. Eligible for Total Transvaginal Laparoscopic Hysterectomy with Salpingo-Oophorectomy or Transvaginal Laparoscopic Hysterectomy with Salpingectomy and have an appropriate indication to go through this surgery.
  4. Willing to undergo laparoscopic transvaginal procedure by Memic HominisTM Surgical System.
  5. Fit for robotic-assisted transvaginal surgery based on surgeon discretion.
  6. Can undergo general anesthesia per anesthesiologist assessment.
Exclusion Criteria
  1. Women with anatomical hazard for laparoscopy and/or vaginal and/or pouch of Douglas access (such as diagnosis of Crohn's disease, active Pelvic inflammatory disease (PID), active diverticulitis, sever peritoneal adhesions, frozen pelvis, obliterated vagina or sever recto-vaginal endometriosis).
  2. Women after pelvic radiation.
  3. Women diagnosed with active intra-abdominal malignancy.
  4. Women with general condition or illness incompatible for surgery.
  5. Women who are pregnant.
  6. Unwillingness or inability to follow the procedures outlined in the protocol.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HominisTM Surgical SystemHominisTM Surgical SystemGynecological surgical procedure will be performed with the HominisTM Surgical System
Primary Outcome Measures
NameTimeMethod
Rate of conversionIntra Operative

Rate of conversion to open or laparoscopic approach

Secondary Outcome Measures
NameTimeMethod
Post-operative procedural outcomesSix weeks post procedure

Re-operation rate

Intra-operative & post-operative procedural outcomesIntra-operative & six weeks post procedure

Mortality

Intra-operative procedural outcomesIntra-operative

Conversion rate (to laparotomy, laparoscopy, other ports used in addition to vaginal and umbilical port).

Vaginal tissue healingSix weeks post procedure

Vaginal tissue healing will be assessed

Trial Locations

Locations (2)

Rambam Hospital

🇮🇱

Haifa, Israel

Imelda Hospital

🇧🇪

Bonheiden, Belgium

© Copyright 2025. All Rights Reserved by MedPath